Ramsay Health Care (OTCMKTS:RMYHY – Get Free Report) and biote (NASDAQ:BTMD – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.
Earnings & Valuation
This table compares Ramsay Health Care and biote”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ramsay Health Care | N/A | N/A | N/A | N/A | N/A |
| biote | $192.22 million | 0.29 | $27.05 million | $0.11 | 14.09 |
Insider & Institutional Ownership
21.7% of biote shares are owned by institutional investors. 32.4% of biote shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current ratings and price targets for Ramsay Health Care and biote, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ramsay Health Care | 1 | 1 | 0 | 0 | 1.50 |
| biote | 1 | 1 | 1 | 1 | 2.50 |
biote has a consensus price target of $2.50, suggesting a potential upside of 61.29%. Given biote’s stronger consensus rating and higher probable upside, analysts plainly believe biote is more favorable than Ramsay Health Care.
Profitability
This table compares Ramsay Health Care and biote’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ramsay Health Care | N/A | N/A | N/A |
| biote | 3.19% | -22.33% | 12.10% |
Risk & Volatility
Ramsay Health Care has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500. Comparatively, biote has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500.
Summary
biote beats Ramsay Health Care on 10 of the 11 factors compared between the two stocks.
About Ramsay Health Care
Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.
About biote
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Receive News & Ratings for Ramsay Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ramsay Health Care and related companies with MarketBeat.com's FREE daily email newsletter.
